Título:	Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale associated with nanoparticles adjuvants.
Autor:	GASPAR, E. B. SANTOS, L. R. dos ARAUJO, F. R. GULIAS-GOMES, C. C. LINCOPAN, N. BRANDAO, H. de M. ROSINHA, G. M. S.
Afiliación:	EMANUELLE BALDO GASPAR, CPPSUL; LENITA RAMIRES DOS SANTOS, CNPGC; FLABIO RIBEIRO ARAUJO, CNPGC; CLAUDIA CRISTINA GULIAS GOMES, CPPSUL; N. LINCOPAN, USP; HUMBERTO DE MELLO BRANDAO, CNPGL; GRACIA MARIA SOARES ROSINHA, CNPGC.
Año:	2012
Referencia:	In: SIMPÓSIO EMBRAPA LABEX EUA DE SANIDADE ANIMAL, 2., 2012, Brasília, DF. Anais... Brasília, DF: Embrapa Estudos e Capacitação, 2012.
Páginas:	p. 153.
Descripción:	This project aims the development of a new vaccine against babesiosis and anaplasmosis based on a chimeric protein and new adjuvants. A chimeric protein formed by Anaplasma marginale VirB9 and Virb10 protein and B. bigemina PO protein will be constructed by genetic engineering.
Thesagro:	Anaplasmose Babesiose Vacina
Tipo de Material:	Resumo em anais e proceedings
Acceso:	openAccess
Aparece en las colecciones:	Resumo em anais de congresso (CNPGL)